Molecular and Immune Assays for Infectious Disease Therapeutics and Vaccines
Accelevir supports infectious disease drug and vaccine development with molecular, sequencing, and immune monitoring assays across bacterial, viral, and fungal pathogens. Our BSL-2+ workflows ensure safe processing of infectious samples while delivering high-sensitivity qPCR/dPCR, NGS, and immunoassay results.
Technical Capabilities:
- Viral load quantification for RNA and DNA pathogens.
- Pathogen-specific immune profiling via ELISpot, ICS, multiplex cytokine panels.
- Antibody isotyping and neutralization assays (via partners).
- Biodistribution and shedding studies for live-attenuated and viral-vectored vaccines.
Why Partner with Accelevir:
- Integrated virology and immunology assay expertise.
- GLP/CLIA-compliant testing for regulated programs.